Last reviewed · How we verify
TCM Syndrome Differentiation Decoction
TCM Syndrome Differentiation Decoction is a Small molecule drug developed by Guangzhou University of Traditional Chinese Medicine. It is currently FDA-approved.
A personalized herbal decoction formulated according to Traditional Chinese Medicine syndrome differentiation principles to restore balance and treat disease-specific patterns.
At a glance
| Generic name | TCM Syndrome Differentiation Decoction |
|---|---|
| Sponsor | Guangzhou University of Traditional Chinese Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
TCM Syndrome Differentiation Decoction is a customized herbal medicine preparation based on individual patient assessment using TCM diagnostic frameworks (e.g., qi/blood/yin/yang imbalances). The specific herbal composition is tailored to address the patient's identified syndrome pattern rather than a single disease entity, aiming to restore physiological harmony through multi-component botanical interactions.
Approved indications
Common side effects
Key clinical trials
- A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients (NA)
- Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study (PHASE4)
- Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study (PHASE4)
- Effect of Acupuncture and Herbal Medicine on Bowel Recovery After Abdominal Surgery (NA)
- Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix. (PHASE2)
- The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients (NA)
- To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer 's Disease (EARLY_PHASE1)
- Comparison Study for Perimenopausal Syndrome With Chinese Herbal Medicine (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TCM Syndrome Differentiation Decoction CI brief — competitive landscape report
- TCM Syndrome Differentiation Decoction updates RSS · CI watch RSS
- Guangzhou University of Traditional Chinese Medicine portfolio CI